These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20354263)

  • 21. Psoriasis and cardiovascular comorbidities with emphasis in Asia.
    Chu TW; Tsai TF
    G Ital Dermatol Venereol; 2012 Apr; 147(2):189-202. PubMed ID: 22481582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T Cells in Obesity.
    Kucharska AM; Pyrżak B; Demkow U
    Adv Exp Med Biol; 2015; 866():35-40. PubMed ID: 26022902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-inflammatory and immune modulation therapy against atherosclerosis].
    Yamashita T; Hirata K
    Nihon Rinsho; 2011 Jan; 69(1):168-72. PubMed ID: 21226279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inflammatory link in atherosclerosis and obesity. Co-stimulatory molecules.
    Zirlik A; Lutgens E
    Hamostaseologie; 2015; 35(3):272-8. PubMed ID: 26225729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.
    Nilsson J; Lichtman A; Tedgui A
    J Intern Med; 2015 Nov; 278(5):507-19. PubMed ID: 25659809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T regulatory cells: a promising new target in atherosclerosis.
    Tselios K; Sarantopoulos A; Gkougkourelas I; Boura P
    Crit Rev Immunol; 2014; 34(5):389-97. PubMed ID: 25404046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Immunol Lett; 2013 Mar; 151(1-2):10-22. PubMed ID: 23411158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells and regulatory T cells in atherosclerosis.
    Cheong C; Choi JH
    Mol Cells; 2012 Oct; 34(4):341-7. PubMed ID: 22752759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.
    van Es T; van Puijvelde GH; Foks AC; Habets KL; Bot I; Gilboa E; Van Berkel TJ; Kuiper J
    Atherosclerosis; 2010 Mar; 209(1):74-80. PubMed ID: 19765709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of Tregs and the complexity in the IL-12 cytokine family signaling in driving T-cell immune responses in atherosclerotic vessels.
    Chistiakov DA; Bobryshev YV; Orekhov AN
    Mol Immunol; 2015 May; 65(1):133-8. PubMed ID: 25659084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells.
    Jiagang D; Li C; Wang H; Hao E; Du Z; Bao C; Lv J; Wang Y
    Biochem Biophys Res Commun; 2011 Aug; 411(3):523-9. PubMed ID: 21756879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.
    Kita T; Yamashita T; Sasaki N; Kasahara K; Sasaki Y; Yodoi K; Takeda M; Nakajima K; Hirata K
    Cardiovasc Res; 2014 Apr; 102(1):107-17. PubMed ID: 24403315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation of conventional T cells into regulatory T cells in children with metabolic syndrome.
    Luczyński W; Wawrusiewicz-Kurylonek N; Bossowski A; Iłendo E; Hryszko M; Krętowski A; Stasiak-Barmuta A
    Kardiol Pol; 2011; 69(12):1221-6. PubMed ID: 22219092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.
    Gotsman I; Grabie N; Gupta R; Dacosta R; MacConmara M; Lederer J; Sukhova G; Witztum JL; Sharpe AH; Lichtman AH
    Circulation; 2006 Nov; 114(19):2047-55. PubMed ID: 17060381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine network and T cell immunity in atherosclerosis.
    Ait-Oufella H; Taleb S; Mallat Z; Tedgui A
    Semin Immunopathol; 2009 Jun; 31(1):23-33. PubMed ID: 19340429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation.
    Wang ZX; Wang CQ; Li XY; Feng GK; Zhu HL; Ding Y; Jiang XJ
    Mol Cell Biochem; 2015 Feb; 400(1-2):163-72. PubMed ID: 25389006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunometabolism of AMPK in insulin resistance and atherosclerosis.
    Fullerton MD; Steinberg GR; Schertzer JD
    Mol Cell Endocrinol; 2013 Feb; 366(2):224-34. PubMed ID: 22361321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.